Therapeutic Targets of Diabetic Retinopathy 1st Edition

Therapeutic Targets of Diabetic Retinopathy (1st Edition) by Weiye Li; Jingfa Zhang is an authoritative, forward-looking resource that zeroes in on the molecular and clinical strategies reshaping care for one of the world’s leading causes of vision loss. This book captures cutting-edge research and practical insights into the pathophysiology, biomarkers, and therapeutic pathways for diabetic retinopathy—making it indispensable for ophthalmologists, endocrinologists, vision scientists, and pharmaceutical researchers.

Discover clear, clinically relevant explanations of key mechanisms—vascular dysfunction, inflammation, neurodegeneration—and how they inform current and emerging treatments such as anti-VEGF approaches, anti-inflammatory agents, gene and cell therapies, and precision-medicine strategies. Each chapter bridges laboratory discoveries with translational and clinical implications, helping readers evaluate new drug targets, design trials, and adopt evidence-based interventions.

Why this title matters: whether you’re a clinician in a busy clinic, a researcher developing next-generation therapeutics, or a postgraduate student specializing in retinal disease, this book delivers practical guidance and a global perspective on diabetic retinopathy management. It emphasizes real-world applicability across diverse healthcare settings in Asia-Pacific, Europe, North America, and beyond.

Well-organized and written by experts Weiye Li and Jingfa Zhang, this 1st edition is both a reference and a roadmap for future innovation in diabetic eye care. Enhance your practice, research, or curriculum with a volume that clarifies complex science and points to actionable therapeutic opportunities.

Order your copy today to stay at the forefront of diabetic retinopathy research and treatment.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.